Company

InterCure Ltd

Headquarters: Herzliya, Israel

Employees: 75

CEO: Mr. Alexander Rabinovich

TASE: INCR -1.80%

Market Cap

₪395.0 Million

ILS as of July 1, 2024

US$104.9 Million

Market Cap History

InterCure Ltd Categories

Israel Healthcare Drug Manufacturers—Specialty & Generic
Israel Healthcare Israel Drug Manufacturers—Specialty & Generic

InterCure Ltd market capitalization over time

Evolution of InterCure Ltd market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of InterCure Ltd

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
Zoetis Inc. $80.13 B
MERCK Kommanditgesellschaft auf Aktien $71.24 B
Takeda Pharmaceutical Company Limited $41.23 B
Haleon plc $37.32 B
Teva Pharmaceutical Industries Limited $18.88 B
Sector:
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Detailed Description

InterCure Ltd, together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Israel and internationally. It also invests in biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

InterCure Ltd has the following listings and related stock indices.


Stock: TASE: INCR wb_incandescent

Stock: OTC: IRCLF wb_incandescent

Stock: NASDAQ: INCR wb_incandescent

Stock: TSX: INCR.U wb_incandescent

Details

Headquarters:

85 Medinat ha-Yehudim Street

Herzliya, 4676670

Israel

Phone: 972 7 7460 5012

Fax: 972 9 768 0244